Parexel Announces Definitive Agreement To Acquire The Medical Affairs Company

Acquisition will strengthen and add scale to current commercialization and medical affairs services.

BOSTON, February 1, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that the Company has entered into a definitive agreement to acquire The Medical Affairs Company, LLC (“TMAC”), a leading provider of outsourced medical affairs services to the pharmaceutical, biotechnology, and medical device industries. The acquisition is expected to close in February. Terms of the transaction were not disclosed. Read more

One Strategic Partnership. Many Solutions.